Viewing Study NCT04123795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:20 PM
Ignite Modification Date: 2026-01-27 @ 5:37 PM
Study NCT ID: NCT04123795
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2019-10-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Moderate Chronic Plaque Psoriasis View
None Severe Chronic Plaque Psoriasis View
None Mixed Guttate/Plaque Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic plaque psoriasis View
None Certolizumab pegol View
None Cimzia View
None Pediatric study View
None Phase 3 View